Literature DB >> 29561195

A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Vanessa Benham1, Debrup Chakraborty1, Blair Bullard1, Jamie J Bernard1.   

Abstract

Obesity is a leading risk factor for post-menopausal breast cancer, and this is concerning as 40% of cancer diagnoses in 2014 were associated with overweight/obesity. Despite this epidemiological link, the underlying mechanism responsible is unknown. We recently published that visceral adipose tissue (VAT) releases FGF2 and stimulates the transformation of skin epithelial cells. Furthermore, obesity is differentially associated with many epithelial cancers, and this mechanistic link could be translational. As FGF2 and FGFR1 are implicated in breast cancer progression, we hypothesize that VAT-derived FGF2 plays a translational role in promoting adiposity-associated mammary epithelial cell transformation. In this brief report, data suggest that FGF2/FGFR1 signaling is a potential mechanistic link in VAT-stimulated transformation of breast epithelial cells.

Entities:  

Keywords:  FGF2; Obesity; adiposity; breast; breast cancer; cancer; visceral fat

Mesh:

Substances:

Year:  2018        PMID: 29561195      PMCID: PMC6152512          DOI: 10.1080/21623945.2018.1445889

Source DB:  PubMed          Journal:  Adipocyte        ISSN: 2162-3945            Impact factor:   4.534


  55 in total

1.  Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.

Authors:  Fred Harbinski; Vanessa J Craig; Sneha Sanghavi; Douglas Jeffery; Lijuan Liu; Kelly Ann Sheppard; Sabrina Wagner; Christelle Stamm; Andreas Buness; Christian Chatenay-Rivauday; Yao Yao; Feng He; Chris X Lu; Vito Guagnano; Thomas Metz; Peter M Finan; Francesco Hofmann; William R Sellers; Jeffrey A Porter; Vic E Myer; Diana Graus-Porta; Christopher J Wilson; Alan Buckler; Ralph Tiedt
Journal:  Cancer Discov       Date:  2012-08-08       Impact factor: 39.397

Review 2.  Carcinogenesis in mouse and human cells: parallels and paradoxes.

Authors:  A Balmain; C C Harris
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

Review 3.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

4.  The FGF/FGFR axis as a therapeutic target in breast cancer.

Authors:  Nicholas Brady; Polly Chuntova; Lindsey K Bade; Kathryn L Schwertfeger
Journal:  Expert Rev Endocrinol Metab       Date:  2013-07

Review 5.  Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-04

6.  Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.

Authors:  Ruo-Lang Pan; Li-Xin Xiang; Ping Wang; Xiao-Yuan Liu; Li Nie; Wendong Huang; Jian-Zhong Shao
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

7.  Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women.

Authors:  K O Hajian-Tilaki; A R Gholizadehpasha; S Bozorgzadeh; E Hajian-Tilaki
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

8.  Visceral obesity and breast cancer risk.

Authors:  D V Schapira; R A Clark; P A Wolff; A R Jarrett; N B Kumar; N M Aziz
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

9.  Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther M John; Mariana C Stern; Jennifer Herrick; Abbie Lundgreen; Anna R Giuliano; Lisa Hines; Kathy B Baumgartner; Gabriela Torres-Mejia; Roger K Wolff
Journal:  Breast Cancer Res Treat       Date:  2013-08-03       Impact factor: 4.872

10.  The -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women.

Authors:  Jan Rykala; Karolina Przybylowska; Ireneusz Majsterek; Grazyna Pasz-Walczak; Andrzej Sygut; Adam Dziki; Piotr Kuna
Journal:  Arch Med Sci       Date:  2014-01-23       Impact factor: 3.318

View more
  9 in total

Review 1.  The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.

Authors:  Jamie J Bernard; Elizabeth A Wellberg
Journal:  Am J Pathol       Date:  2021-02-24       Impact factor: 5.770

2.  Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay.

Authors:  Vanessa Benham; Blair Bullard; Thomas S Dexheimer; Matthew P Bernard; Richard R Neubig; Karen T Liby; Jamie J Bernard
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

3.  Obesity induced by high-fat diet is associated with critical changes in biological and molecular functions of mesenchymal stromal cells present in visceral adipose tissue.

Authors:  Mustafa Burak Acar; Şerife Ayaz-Güner; Giovanni Di Bernardo; Hüseyin Güner; Ayşegül Murat; Gianfranco Peluso; Servet Özcan; Umberto Galderisi
Journal:  Aging (Albany NY)       Date:  2020-12-27       Impact factor: 5.682

Review 4.  Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments.

Authors:  Erika Aparecida Silveira; Golnaz Vaseghi; Annelisa Silva de Carvalho Santos; Nathalie Kliemann; Farzad Masoudkabir; Matias Noll; Noushin Mohammadifard; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

5.  The Use of Human Serum Samples to Study Malignant Transformation: A Pilot Study.

Authors:  Andreana N Holowatyj; Biljana Gigic; Christy A Warby; Jennifer Ose; Tengda Lin; Petra Schrotz-King; Cornelia M Ulrich; Jamie J Bernard
Journal:  Cells       Date:  2021-10-06       Impact factor: 6.600

Review 6.  Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management.

Authors:  Rosario Le Moli; Veronica Vella; Dario Tumino; Tommaso Piticchio; Adriano Naselli; Antonino Belfiore; Francesco Frasca
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

7.  A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.

Authors:  Taekyu Kang; Christina Yau; Christopher K Wong; John Z Sanborn; Yulia Newton; Charlie Vaske; Stephen C Benz; Gregor Krings; Roman Camarda; Jill E Henry; Josh Stuart; Mark Powell; Christopher C Benz
Journal:  Breast Cancer Res       Date:  2020-07-31       Impact factor: 6.466

8.  PTEN: A Thrifty Gene That Causes Disease in Times of Plenty?

Authors:  Ajit Venniyoor
Journal:  Front Nutr       Date:  2020-06-05

9.  The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors.

Authors:  Wyatt Boothby-Shoemaker; Vanessa Benham; Shreya Paithankar; Rama Shankar; Bin Chen; Jamie J Bernard
Journal:  Cells       Date:  2020-10-01       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.